Interferon beta-1a Completed Phase 2 Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00099489Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)